Robert E. Davis, SVP, Chief Scientific Officer at Intra-Cellular Therapies, Inc. (ITCI), sold 16,426 shares at $11.33 ($187K) on 2019-01-04, disclosed to the SEC on 2019-01-08.
Open-market sale of $187k ITCI by SVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.33 | 6,862 | $78K | 41.5% |
| 2 | $11.33 | 6,862 | $78K | 41.5% |
| 3 | $11.80 | 2,702 | $32K | 17.0% |
| Total | $11.41 avg | 16,426 | $187K | 100% |
| Filing → |
| ITCI | SELL | 2018-01-05 | $17K | — | Filing → |
| ITCI | SELL | 2017-12-06 | $10K | — | Filing → |